Evotec OAI and Rib-X Pharmaceuticals Enter Into Medicinal Chemistry Collaboration


Evotec OAI AG and Rib-X Pharmaceuticals, Inc., announced the Formation of a medicinal chemistry partnership.

Scientists from Rib-X and Evotec OAI will collaborate on several research programmes. Evotec OAI will be utilising its state-of-the-art integrated medicinal chemistry and parallel synthesis platform to facilitate Rib-X's efforts to identify novel antibiotics for clinical development.

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics